跳至主要内容
临床试验/IRCT20220110053680N1
IRCT20220110053680N1已完成3 期

Evaluation of the effect of aspirin consumption on permanent Internal Jugular dialysis catheter patency in End Stage Renal Disease (ESRD) patients

Zanjan University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • The patient has ESRD and Glomerular Filtration Rate (GFR) <15ml / min / 1.73 m^2.
  • At least one month should be passed since the start of hemodialysis maintenance.
  • At least one month and at most one year should be passed since the installation of the internal jugular permcath .
  • There shouldn't have any definitive contraindication for normal use of aspirin

排除标准

  • Current aspirin use at the time of entrance in the study
  • Presence of a known underlying disease that increases the risk of thrombosis (lupus, antiphospholipid syndrome, presence of nephrotic syndromes)
  • use of anticoagulants (warfarin, heparin, apixaban, rivaroxaban, plavix)
  • use of Tarulac
  • Catheter infection before beginning the study
  • Incomplete patient document regarding the items required in the study
  • Patient disfavor with inclusion in the study

研究者

相似试验